HUP9901438A2 - Terápiás hatású pirimidinszármazékok - Google Patents
Terápiás hatású pirimidinszármazékokInfo
- Publication number
- HUP9901438A2 HUP9901438A2 HU9901438A HUP9901438A HUP9901438A2 HU P9901438 A2 HUP9901438 A2 HU P9901438A2 HU 9901438 A HU9901438 A HU 9901438A HU P9901438 A HUP9901438 A HU P9901438A HU P9901438 A2 HUP9901438 A2 HU P9901438A2
- Authority
- HU
- Hungary
- Prior art keywords
- hydrogen atom
- deoxyglucopyranosyl
- oac
- pipe powder
- acyl
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 8
- 239000000843 powder Substances 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- IVWWFWFVSWOTLP-YVZVNANGSA-N (3'as,4r,7'as)-2,2,2',2'-tetramethylspiro[1,3-dioxolane-4,6'-4,7a-dihydro-3ah-[1,3]dioxolo[4,5-c]pyran]-7'-one Chemical compound C([C@@H]1OC(O[C@@H]1C1=O)(C)C)O[C@]21COC(C)(C)O2 IVWWFWFVSWOTLP-YVZVNANGSA-N 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Percussion Or Vibration Massage (AREA)
- Steroid Compounds (AREA)
- Pyrane Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
A találmány tárgya az (I) általánős képletű vegyületek - ahől aképletben R jelentése halőgénatőm, Y jelentése hidrőgénatőm, -NH2, -SH vagy -OH csőpőrt, X jelentése (a) általánős képletű csőpőrt, amelyben vagy R1 vagy R2 egy kötés, és a másik hidrőgénatőm, vagy R3 vagy R4 hidrőgénatőm, és a másik hidrőgénatőm, -OH, -OAc vagy -NHAcképletű csőpőrt, vagy R5 -OH csőpőrt vagy -OAc csőpőrt, vagy R7 vagy R8 hidrőgénatőm, és a másik -OH vagy -OAc csőpőrt, R9 hidrőgénatőm, -CH2OH vagy -CH2OAc csőpőrt - és enantiőmerjeik,azzal a kikötéssel, hőgy ha R4 jelentése -OH, -OAc vagy -NHAc csőpőrt, akkőr R8 jelentésehidrőgénatőm; és ha R3 jelentése hidrőgénatőm vagy hidrőxilcsőpőrt, és R4 jelentésehidrőgénatőm, és R5, R7 és R8 jelentése hidrőxilcsőpőrt, akkőr avegyület az L-enantiőmertől eltérő főrmában van; és ha R4, R5 és R7 jelentése egyaránt -OAc csőpőrt, akkőr R9 jelentése -CH2OH csőpőrttól eltérő; és a vegyületek a 2-dezőxi--D-ribőpiranőzil-bróm-5-űraciltól, a 2-dezőxi-a-D-ribőpiranőzil-1-bróm-5-űraciltól, az1-(-D-2-dezőxi-glűkőpiranőzil)-5-flűőr-űraciltól, az 1-(a-D-2-dezőxi-glűkőpiranőzil)-5-flűőr-űraciltól, az 1-(a-D-2-dezőxi-glűkőpiranőzil)-5-bróm-űraciltól, az 1-(-D-2-dezőxi-glűkőpiranőzil)-5-bróm-űraciltól,az 1-(-D-2-dezőxi-glűkőpiranőzil)-5-bróm-űraciltól, az 1-(a-D-2-dezőxi-glűkőpiranőzil)-5-jód-űraciltól és az 1-(-D-2-dezőxi-glűkőpiranőzil)-5-jód-űraciltól eltérőek. ŕ
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9512868.2A GB9512868D0 (en) | 1995-06-23 | 1995-06-23 | Therapeutic compounds |
| GBGB9608372.0A GB9608372D0 (en) | 1996-04-23 | 1996-04-23 | Therapeutic compounds |
| GBGB9608547.7A GB9608547D0 (en) | 1996-04-25 | 1996-04-25 | Therapeutic compounds |
| US1676296P | 1996-05-03 | 1996-05-03 | |
| US1697396P | 1996-05-07 | 1996-05-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9901438A2 true HUP9901438A2 (hu) | 1999-08-30 |
| HUP9901438A3 HUP9901438A3 (en) | 2000-07-28 |
Family
ID=27517294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9901438A HUP9901438A3 (en) | 1995-06-23 | 1996-06-24 | Therapeutic pyrimidine compounds |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5945406A (hu) |
| EP (1) | EP0851866B1 (hu) |
| JP (1) | JPH11507942A (hu) |
| KR (1) | KR19990028344A (hu) |
| CN (1) | CN1196059A (hu) |
| AT (1) | ATE204878T1 (hu) |
| AU (1) | AU6234296A (hu) |
| CA (1) | CA2225247A1 (hu) |
| DE (1) | DE69614867T2 (hu) |
| ES (1) | ES2162078T3 (hu) |
| HU (1) | HUP9901438A3 (hu) |
| ID (1) | ID16479A (hu) |
| IL (1) | IL122700A0 (hu) |
| NO (1) | NO976043L (hu) |
| PL (1) | PL328266A1 (hu) |
| WO (1) | WO1997000882A1 (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997000882A1 (en) * | 1995-06-23 | 1997-01-09 | Oxford Glycosciences (Uk) Limited | Therapeutic compounds |
| DE19741738A1 (de) * | 1997-09-22 | 1999-03-25 | Hoechst Ag | Linker-Nucleosid, seine Herstellung und Verwendung |
| DE19741715A1 (de) | 1997-09-22 | 1999-03-25 | Hoechst Ag | Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung |
| DE19837387A1 (de) | 1998-08-18 | 2000-02-24 | Aventis Res & Tech Gmbh & Co | 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung |
| US6344460B1 (en) * | 1999-03-19 | 2002-02-05 | Lonza Inc. | Propynyl uracils |
| US20050143300A1 (en) * | 2003-10-10 | 2005-06-30 | Ma Jian-Xing | Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same |
| JP5677951B2 (ja) * | 2008-07-11 | 2015-02-25 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 抗癌活性を有する２−デオキシ単糖の新規なアセテート |
| WO2014165736A2 (en) | 2013-04-05 | 2014-10-09 | Board Of Regents, The University Of Texas System | Esters of 2-deoxy-monosaccharides with anti proliferative activity |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3354160A (en) * | 1965-07-22 | 1967-11-21 | Hoffmann La Roche | Tri-lower alkyl-silyl-5-fluoropyrimidines |
| DK149818C (da) * | 1976-10-28 | 1987-04-06 | Sankyo Co | Analogifremgangsmaade til fremstilling af 5-fluoruracil-derivater |
| US4248999A (en) * | 1976-10-28 | 1981-02-03 | Sankyo Company Limited | 5-Fluorouracil derivatives and process for preparing thereof |
| JPS55153796A (en) * | 1979-05-21 | 1980-11-29 | Meiji Seika Kaisha Ltd | 5-fluorouracil nucleoside and its preparation |
| JPS5829798A (ja) * | 1981-08-15 | 1983-02-22 | Tetsuo Suami | ヌクレオシド類似体 |
| JPS5872599A (ja) * | 1981-10-27 | 1983-04-30 | Kanto Ishi Pharma Co Ltd | 複合糖質誘導体 |
| EP0119650A3 (en) * | 1983-03-21 | 1987-09-30 | THE PROCTER & GAMBLE COMPANY | Galactosyl-insulin conjugates useful in treating diabetics |
| JP2696393B2 (ja) * | 1989-05-09 | 1998-01-14 | 株式会社日本抗体研究所 | チミン誘導体及びこれを含有する抗ｈｉｖ剤 |
| JPH0517494A (ja) * | 1991-07-10 | 1993-01-26 | Nippon Shoji Kk | グルコサミン誘導体 |
| ATE284894T1 (de) * | 1994-10-24 | 2005-01-15 | Genencor Int | L-pyranosyl-nukleoside |
| WO1997000882A1 (en) * | 1995-06-23 | 1997-01-09 | Oxford Glycosciences (Uk) Limited | Therapeutic compounds |
| GB9626450D0 (en) * | 1996-12-20 | 1997-02-05 | Oxford Glycosciences Uk Ltd | Therapeutic compounds |
-
1996
- 1996-06-24 WO PCT/GB1996/001519 patent/WO1997000882A1/en not_active Application Discontinuation
- 1996-06-24 ES ES96920967T patent/ES2162078T3/es not_active Expired - Lifetime
- 1996-06-24 EP EP96920967A patent/EP0851866B1/en not_active Expired - Lifetime
- 1996-06-24 DE DE69614867T patent/DE69614867T2/de not_active Expired - Fee Related
- 1996-06-24 AU AU62342/96A patent/AU6234296A/en not_active Abandoned
- 1996-06-24 ID IDP961794A patent/ID16479A/id unknown
- 1996-06-24 PL PL96328266A patent/PL328266A1/xx unknown
- 1996-06-24 KR KR1019970709659A patent/KR19990028344A/ko not_active Application Discontinuation
- 1996-06-24 IL IL12270096A patent/IL122700A0/xx unknown
- 1996-06-24 CA CA002225247A patent/CA2225247A1/en not_active Abandoned
- 1996-06-24 CN CN96196248A patent/CN1196059A/zh active Pending
- 1996-06-24 AT AT96920967T patent/ATE204878T1/de active
- 1996-06-24 HU HU9901438A patent/HUP9901438A3/hu unknown
- 1996-06-24 JP JP9503686A patent/JPH11507942A/ja not_active Ceased
-
1997
- 1997-12-22 NO NO976043A patent/NO976043L/no not_active Application Discontinuation
- 1997-12-23 US US08/997,309 patent/US5945406A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ID16479A (id) | 1997-10-02 |
| DE69614867T2 (de) | 2002-04-11 |
| KR19990028344A (ko) | 1999-04-15 |
| EP0851866A1 (en) | 1998-07-08 |
| WO1997000882A1 (en) | 1997-01-09 |
| HUP9901438A3 (en) | 2000-07-28 |
| US5945406A (en) | 1999-08-31 |
| CN1196059A (zh) | 1998-10-14 |
| EP0851866B1 (en) | 2001-08-29 |
| MX9710529A (es) | 1998-08-30 |
| JPH11507942A (ja) | 1999-07-13 |
| IL122700A0 (en) | 1998-12-06 |
| NO976043L (no) | 1998-02-20 |
| ES2162078T3 (es) | 2001-12-16 |
| CA2225247A1 (en) | 1997-01-09 |
| AU6234296A (en) | 1997-01-22 |
| PL328266A1 (en) | 1999-01-18 |
| DE69614867D1 (de) | 2001-10-04 |
| ATE204878T1 (de) | 2001-09-15 |
| NO976043D0 (no) | 1997-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0873340T3 (da) | Heterocyklisk substituerede cyclopentanforbindelser | |
| HUP0102466A2 (hu) | Antiösztrogén hatású új benzo-pirán vagy tiobenzo-pirán származékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények | |
| ES2096328T3 (es) | Nuevo procedimiento para la esterificacion de la bacatina iii y de la desacetil-10 bacatina iii. | |
| HUP9901438A2 (hu) | Terápiás hatású pirimidinszármazékok | |
| HUP9901150A2 (hu) | Baktériumok kolonizációjának gátlására szolgáló oligoszacharidokat tartalmazó gyógyszerkészítmény | |
| DE69318503T2 (de) | Ein definiertes lipidsystem enthaltende pharmazeutische zusammensetzung | |
| BRPI0509471A8 (pt) | Lipídios, complexos de lipídio e uso dos mesmos | |
| FI951885A (fi) | Kohinaa vaimentava differentiaalinen mikrofonikokoonpano | |
| ES2188584T3 (es) | Derivados heterociclicos de amina. | |
| PA8481301A1 (es) | Derivados de 4,4-biarilpiperidina | |
| ATE196643T1 (de) | Anwuchsverhindernde zusammensetzungen | |
| DE19875032I2 (de) | Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen | |
| NO20002803L (no) | FremgangsmÕte for fremstilling av korrosjonsinhiberende filmer med hydrogenerte benzotriazolderivater | |
| FI946043A0 (fi) | Sokeripäällysteinen farmaseuttinen annosyksikkö | |
| TR199701254T1 (xx) | 5-HT al�� inhibit�r�n�n selektif 5-HT1A antagonistiyle kombinasyonu. | |
| DE69801594D1 (de) | Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung | |
| CA2085345A1 (en) | Pyrimidine nucleoside derivatives | |
| DE60023758D1 (en) | Glycerophosphoinositol-derivate als cytosolic a2 phospholipase modulatoren | |
| ES2105285T3 (es) | Nuevos derivados de la adenosina, sus procedimientos de preparacion, composiciones farmaceuticas que los contienen. | |
| HUP9904301A2 (hu) | Benzimidazolszármazékok,valamint ezeket tartalmazó gyógyászati készítmények | |
| CS9100438A2 (en) | New derivative of beta-phenylisoserine, method of its preparation and its application | |
| ES2076838T3 (es) | Nuevo derivado de la isoindolinona, su preparacion y las composiciones farmaceuticas que le contienen. | |
| BR0313150A (pt) | Cápsulas de gelatina que exibem ligação reticulada reduzida | |
| ES8608462A1 (es) | Un procedimiento para la preparacion de nuevos derivados del acetileno. | |
| DK0788491T3 (da) | 6-Polyfluoralkoxy- og 6-polyfluoralkyl-2-aminobenzothiazol-derivater |